M11.12
Familial chondrocalcinosis, elbow
Clinical Classification Guidelines
Medical Intelligence & Overview
Familial chondrocalcinosis of the elbow is a hereditary condition characterized by the abnormal deposition of calcium pyrophosphate crystals in the cartilage of the elbow joint. This disorder often runs in families and can lead to joint discomfort, stiffness, and reduced mobility over time. Recognized under the ICD-10 code M11.12, it is a specific form of calcium pyrophosphate deposition disease (CPPD), primarily affecting the elbows, though it might involve other joints as well. While it is hereditary, the condition's severity and progression can vary among individuals. Understanding its causes, symptoms, diagnosis, and management options can help affected individuals and their healthcare providers manage the condition effectively.
Causes & Symptoms
Clinical Causes: Genetic predisposition due to inherited mutations affecting cartilage or calcium metabolism Presence of familial traits that increase susceptibility to crystal deposition Age-related changes that increase likelihood of crystal formation Potential environmental factors that may influence disease progression, although less defined
Key Symptoms: Joint pain, especially during movement Swelling and tenderness around the elbow joint Stiffness, making movement difficult Reduced range of motion in affected elbows Occasional warmth and redness in the joint area Possible episodic flare-ups with increased discomfort
Diagnostic & Treatment
Diagnosis Path: Diagnosis of familial chondrocalcinosis of the elbow involves a combination of clinical evaluation and laboratory tests. Healthcare providers may perform a physical examination to assess joint swelling, tenderness, and range of motion. Imaging studies, such as X-rays, are used to detect calcium deposits within the cartilage of the elbow. These deposits appear as white, radiopaque areas on the scans. Arthrocentesis, or joint fluid aspiration, can be performed to analyze the synovial fluid. The presence of calcium pyrophosphate crystals in the joint fluid confirms the diagnosis. Sometimes, blood tests are conducted to rule out other conditions and to assess overall joint health.
Treatment Protocols: While there is no cure for familial chondrocalcinosis, various management strategies aim to control symptoms and slow disease progression. Treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is M11.12 a billable ICD-10 code?
Yes, M11.12 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.12?
Clinical documentation must specify the nature of Familial chondrocalcinosis, elbow and any associated comorbidities for accurate reporting.
Cite this Clinical Reference